Item 9 Labs adds director
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
Item 9 Labs Corp. has appointed Andrew Bowden to its board.
Bowden serves as co-founder and CEO of Bowden Investment Group, an investment firm.
Scottsdale, Ariz.-based Item 9 Labs develops, manufactures and distributes nasal breathing devices.